Dr. Marcus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Karuna Therapeutics
Boston, MA 02110Phone+1 203-376-3914
Summary
- Bristol-Myers Squibb, SVP Clinical Development in Psychiatry
Karuna Therapeutics SVP Clinical Development
Supernus - VP of R&D
Cerecor - Chief Medical Officer and Head of Regulatory Affairs
Spinifex Pharmaceuticals - Chief Medical Officer
Bristol Myers Squibb - 23 years, Executive Director Neuroscience Clinical Research
Education & Training
- NewYork–Presbyterian/Westchester DivisionFellowship, 1987 - 1989
- New York Presbyterian Hospital (Cornell Campus)/WestchesterResidency, Psychiatry, 1984 - 1987
- Nassau University Medical CenterInternship, Internal Medicine, 1983 - 1984
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1983
- University of VirginiaBA, Psychology, 1975 - 1979
Certifications & Licensure
- MD State Medical License 2022 - 2025
- CT State Medical License 1985 - 2022
- NY State Medical License 1984 - 1992
- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 7 citationsA proposed anti-maladaptive aggression agent classification: improving our approach to treating impulsive aggression.Adelaide S. Robb, Stefan Schwabe, Gianpiera Ceresoli-Borroni, Azmi Nasser, Chungping Yu
Postgraduate Medicine. 2019-02-14 - 9 citationsEfficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy.J. Craig Nelson, Zia Rahman, Kimberly K. Laubmeier, James M. Eudicone, Robert D. McQuade
CNS Spectrums. 2014-12-01 - 16 citationsComparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patien...Anita H. Clayton, Ross A. Baker, John J. Sheehan, Zachary Cain, Robert A. Forbes
BMC Research Notes. 2014-07-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: